Yupei Zhao is a professor in surgery, chief physician, and Ph.D. supervisor, who is also the leader of general surgery in China and an academician of the Chinese Academy of Sciences elected in 2011.

Prof. Zhao has been practicing medicine for over 40 years, during which he’s been working on the frontline of clinical care, research, and education. He has accomplished much innovative work in hepatopancreatology, gastroenterology, and thyroid diseases and made spectacular achievements in pancreatic diseases. The “Pancreatic Cancer Treatment Easy Access” he established standardized domestic process of pancreatic cancer diagnosis and treatment. He founded the first consulting center for pancreatic disease in China that enabled patients’ timely access to the best therapeutic strategies through multi-disciplinary treatment (MDT), which is of great significance for the sensible use of medical resources and the efficacy of surgeries. Besides, his optimization of the indications and procedures of surgeries and the clinical support for the perioperative period dramatically reduced mortality and complications of pancreatic cancer surgeries. The transjejunal gastrostomy he invented also minimized complications of indwelled stomach tubes. He carried out clinical research on the diagnosis and surgical treatment of pancreatic neuroendocrine tumors and successfully completed China’s first laparoscopic resection of insulinoma and became a pioneer in employing robotics for insulinoma surgeries in China. He conducted substantial basic research about the complex problems of the diagnosis and treatment of pancreatic cancer and contributed to advancing the progress and development of pancreatic surgeries with his guidance and collaborations with his fellow pancreatic surgeons. He is also the leader in formulating the guidelines for the diagnosis and treatment of pancreatic cancer by the Chinese Medical Association and the national industry standard for the diagnosis and treatment of pancreatic cancer of the Ministry of Health. He led sixteen pancreatic surgery centers nationwide to undertake several national key research projects, such as 863, 973, science and technology support plan, and special industrial funds, and with his establishment of the big data center for pancreatic diseases in China, he conducted prospective clinical research on critical problems in the diagnosis and treatment of pancreatic cancer and constructed a national technological platform for improving the diagnosis and treatment of pancreatic cancer. Prof. Zhao receives State Council special allowance and has been honored with the National Science and Technology Progress Award.

FIELD:

Hepatobiliary pancreas, gastrointestinal, thyroid and other general fields.

Membership:

̶ Honorary President, Peking Union Medical College Hospital

̶ President, Chinese Medical Association

̶ Chairman of the Surgery Branch, Chinese Medical Association

̶ Director, National Pancreatic Surgery Division

̶ Vice President, International Association for Gastrointestinal, Hepatobiliary and Pancreatic Surgery

Publications:

More than 100 SCI articles with the first and communications author, such as Ann Surg, Gut，J Hematol Oncol，Cell Res，et al. The total impact factor is more than 400 points with the highest impact factor 20.507 points.

Awards

̶ 2^nd Place in the National Science and Technology Progress Award (twice)

̶ 1^st Prize in the Beijing Science and Technology Progress Award

̶ 1^st Prize in the Chinese Medical Science and Technology Progress Award

̶ The Ho Leung Ho Lee Foundation Science and Technology Progress Award

̶ Elected project (the Pancreatology journal) for the “Three 100s” original book publication project of the National Press and Publication Administration

̶ Zhou Guangzhao Clinical Physician Award

̶ The Chinese Physician Award

̶ Young-and-Middle-aged Experts with Outstanding Contribution Award of the Ministry of Health

̶ Role Model of Medical Ethics of Beijing

̶ Advanced Individual of Teachers' Ethics of Beijing

̶ National Labor Medal